Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06203509 · ClinicalTrials.gov registry record · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
A NA study of Care Transitions, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 267
- Enrollment target
- 1
- Study location
NCT06203509: Recruiting NA study of Care Transitions, sponsored by University of Pennsylvania.
NCT06203509 is a NA study of Care Transitions that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 267 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06203509, a NA study of Care Transitions, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 267 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the THRIVE clinical pathway at HUP, focusing on supporting Medicaid-insured individuals, including those with serious mental illness, following hospitalization. The study will assess clinician/administrator perspectives on the pathway's feasibility, appropriateness, and acceptability and analyze referral patterns and post-discharge outcomes. The objectives are: 1. To conduct a qualitative study evaluating the implementation of THRIVE, particularly its adaptation to include patients with serious mental illness. 2. To examine referral patterns, 30-day readmission rates, and ED utilization for THRIVE participants, comparing them with those receiving standard care. Participants will be referred to home care services during hospitalization and seen by a home care nurse within 48 hours post-discharge. A discharging physician or Advanced Practice Provider will oversee care for 30 days or until a primary care or specialist visit. The Care Coordination Team will hold weekly case conferences for 30 days post-discharge to address both health and mental health needs. The study will compare outcomes of Medicaid-insured patients, including those with serious mental illness, to those receiving usual care.
Primary Outcome
We will evaluate changes in home care referrals between case managers exposed to the intervention compared to those who were not
Conditions Studied
Interventions
- BEHAVIORAL Thrive Intervention
Study Locations (1)
Pennsylvania
- Upenn School of Nursing Centre For Health Outcomes Policy Research - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What NCT06203509 shows while recruiting
NCT06203509 is an interventional study that assigns participants to a tested intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Care Transitions appearing as the primary indexed condition, and to 1 intervention - of which Thrive Intervention is the first listed.
NCT06203509 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06203509 about?
NCT06203509 is a clinical study titled "Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness". This study aims to evaluate the THRIVE clinical pathway at HUP, focusing on supporting Medicaid-insured individuals, including those with serious mental illness, following hospitalization. The study will assess clinician/administrator perspectives on the pathway's feasibility, appropriateness, and a...
What is the current status of trial NCT06203509?
This trial is currently recruiting. It is a NA study. The enrollment target is 267 participants. The study started on 2024-04-15. Estimated completion is 2026-10-01.
What conditions does trial NCT06203509 study?
This clinical trial studies the following conditions: Care Transitions.
What interventions are being tested in trial NCT06203509?
The interventions under investigation include: Thrive Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06203509?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06203509 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Care Transitions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06203509's enrollment target sits among peer trials
267 395th of 2000 higher than 1,606 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI